In 2010, the INCB prepared a report entitled: ‘Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes’, analysing the global situation in the consumption of internationally controlled substances. The ‘Availability Report’ identified the main barriers to adequate availability and provided recommendations on how problems can be addressed.
The INCB is asking organisations to provide supplementary information on the consumption of internationally controlled substances at national and global levels. This information could comprise statistics, data, studies and academic articles.
Also, case studies that reflect challenges and barriers with regard to availability of controlled substances as well as examples of best practices in the facilitation of access to such substances would be highly welcome.
The INCB is mandated to monitor the implementation of the international drug control conventions to ensure adequate availability of narcotic drugs and psychotropic substances for medical and scientific purposes while ensuring that such drugs are not diverted for illicit purposes.
The INCB has repeatedly voiced its concern about the disparate and inadequate access to controlled substances for medical and scientific purposes worldwide.
The information must reach INCB by 31 January 2015.
Please also circulate this request to your members and to other organizations that you believe would be in a position to provide a useful contribution.